WBA
67
4
HPE
50
4
MRK
32
2
MA
69
5
MMC
62
2
R
66
3
LMT
49
4
BA
56
3
SHW
67
2
CNX
56
4
DRI
48
3
GE
67
2
KIM
73
4
DAL
85
6
CFG
50
-6
AXP
73
3
NTAP
64
3
GRMN
48
2
DOV
69
4
HRL
30
3
WBA
67
4
HPE
50
4
MRK
32
2
MA
69
5
MMC
62
2
R
66
3
LMT
49
4
BA
56
3
SHW
67
2
CNX
56
4
DRI
48
3
GE
67
2
KIM
73
4
DAL
85
6
CFG
50
-6
AXP
73
3
NTAP
64
3
GRMN
48
2
DOV
69
4
HRL
30
3
Financhill
Back

ProShares Ultra MSCI Brazil Capped Vs. Kymera Therapeutics Industry Stock Comparison

Sell
50

UBR
ProShares Ultra MSCI Brazil Capped

Last Price:
21.00
Seasonality Move:
2.92%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Sell
50
ProShares Ultra MSCI Brazil Capped (UBR) is a Sell

Is ProShares Ultra MSCI Brazil Capped a Buy, Sell or Hold?

  • The current ProShares Ultra MSCI Brazil Capped [UBR] share price is $21.14. The Score for UBR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • UBR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UBR Stock Price Chart

What is ProShares Ultra MSCI Brazil Capped's stock price today?

  • The ProShares Ultra MSCI Brazil Capped share price today is $21.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UBR is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

UBR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.59 Sell
Relative Strength Index (14 RSI): 39.23 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.68 - 23.72) Sell
Bollinger Bands (100): (21.01 - 23.99) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

UBR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.47 Sell
20-day SMA: 22.41 Sell
50-day SMA: 23.34 Sell
200-day SMA: 25.58 Sell
8-day EMA: 21.54 Sell
20-day EMA: 22.21 Sell
50-day EMA: 22.75 Sell
200-day EMA: 24.53 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

ProShares Ultra MSCI Brazil Capped Earnings Growth & UBR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

ProShares Ultra MSCI Brazil Capped Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):